These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 10749516)

  • 1. Is there a role for therapeutic drug monitoring of new anticonvulsants?
    Perucca E
    Clin Pharmacokinet; 2000 Mar; 38(3):191-204. PubMed ID: 10749516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring serum levels of new antiepileptics].
    Armijo JA; Adín-Ibarra J; Sánchez-Baglietto N; Vega-Gil N
    Rev Neurol; 2002 Sep; 35 Suppl 1():S116-34. PubMed ID: 12373664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring of the newer antiepileptic drugs.
    Johannessen SI; Battino D; Berry DJ; Bialer M; Krämer G; Tomson T; Patsalos PN
    Ther Drug Monit; 2003 Jun; 25(3):347-63. PubMed ID: 12766564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic monitoring of the new antiepileptic drugs.
    Tomson T; Johannessen SI
    Eur J Clin Pharmacol; 2000 Jan; 55(10):697-705. PubMed ID: 10663446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs.
    Jacob S; Nair AB
    Drugs R D; 2016 Dec; 16(4):303-316. PubMed ID: 27766590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing serum topiramate concentrations in routine therapeutic drug monitoring in Korean adult patients with epilepsy.
    Huh HJ; Joo EY; Hong SB; Ahn JH; Seo DW; Lee SY
    Ther Drug Monit; 2013 Apr; 35(2):177-82. PubMed ID: 23503443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.
    Yukawa E
    Clin Pharmacokinet; 1996 Aug; 31(2):120-30. PubMed ID: 8853934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can pharmacokinetic variability be controlled for the patient's benefit? The place of TDM for new AEDs.
    Johannessen SI
    Ther Drug Monit; 2005 Dec; 27(6):710-3. PubMed ID: 16404799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Drug Monitoring of Newer Antiepileptic Drugs: A Randomized Trial for Dosage Adjustment.
    Aícua-Rapún I; André P; Rossetti AO; Ryvlin P; Hottinger AF; Decosterd LA; Buclin T; Novy J
    Ann Neurol; 2020 Jan; 87(1):22-29. PubMed ID: 31714640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug analysis during epilepsy treatment is valuable].
    Tomson T
    Lakartidningen; 1997 Jun; 94(26-27):2461-4. PubMed ID: 9235444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
    Patsalos PN; Berry DJ
    Ther Drug Monit; 2013 Feb; 35(1):4-29. PubMed ID: 23288091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and clinical applications of the dried blood spot method for therapeutic drug monitoring of anti-epileptic drugs.
    Min KL; Ryu JY; Chang MJ
    Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):215-236. PubMed ID: 31199557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects.
    Johannessen Landmark C; Johannessen SI; Patsalos PN
    Expert Opin Drug Metab Toxicol; 2020 Mar; 16(3):227-238. PubMed ID: 32054370
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice.
    Johannessen Landmark C; Beiske G; Baftiu A; Burns ML; Johannessen SI
    Seizure; 2015 May; 28():88-91. PubMed ID: 25758302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.
    Patsalos PN; Berry DJ; Bourgeois BF; Cloyd JC; Glauser TA; Johannessen SI; Leppik IE; Tomson T; Perucca E
    Epilepsia; 2008 Jul; 49(7):1239-76. PubMed ID: 18397299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic variability, efficacy and tolerability of eslicarbazepine acetate-A national approach to the evaluation of therapeutic drug monitoring data and clinical outcome.
    Svendsen T; Brodtkorb E; Reimers A; Molden E; Sætre E; Johannessen SI; Johannessen Landmark C
    Epilepsy Res; 2017 Jan; 129():125-131. PubMed ID: 28043062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of old and newer anti-epileptic drugs.
    Neels HM; Sierens AC; Naelaerts K; Scharpé SL; Hatfield GM; Lambert WE
    Clin Chem Lab Med; 2004; 42(11):1228-55. PubMed ID: 15576287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Principles of therapeutic drug monitoring].
    Widmer N; Csajka C; Werner D; Grouzmann E; Decosterd LA; Eap CB; Biollaz J; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1644-8. PubMed ID: 18767290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
    Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.